Dr. Alizaidy's peptide 'backfilling' method, fact-checked
Quick answer
The video demonstrates a syringe backfilling technique to consolidate multiple peptide doses into a single subcutaneous injection, using a 29-gauge draw needle and a 30-gauge injection needle. While the mechanical steps are largely accurate, the creator does not address peptide chemical compatibility when mixed in a single syringe, potential dose loss from acknowledged leakage, or contamination risks introduced by the multi-step transfer process. Anyone using peptide therapy should confirm preparation technique with a licensed prescriber or compounding pharmacist, not a social media tutorial.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @gabrielalizaidy actually say?
The creator demonstrated a technique called "backfilling" to combine multiple peptide doses into a single syringe, avoiding what she described as four separate injections from four vials. She drew each peptide into a larger-gauge needle, removed the plunger from a finer injection needle, transferred the fluid into the back of that syringe, then carefully managed an air bubble before reinserting the plunger. Her core instruction was to get "that air bubble to the top" before pushing the plunger back in, to avoid expelling fluid. She also noted she structures her doses so "all my vials, the math comes out to 30 units" for consistency. The technique itself is real and used in compounding and home injection settings. The question is whether she explained it accurately and safely enough for a general audience following along on TikTok.
Does the science back this up?
Backfilling syringes is a legitimate technique, primarily documented in insulin and subcutaneous hormone injection literature, but the evidence base for peptide stacking specifically is thin. That said, the mechanical principle is sound.
Syringe backfilling is well described in nursing and pharmacy compounding literature. A 2019 review in the Journal of Diabetes Science and Technology (Heinemann et al.) discussed the accuracy of insulin syringe loading methods, finding that backfilling introduces minor volume variability compared to direct draw, but not clinically significant amounts in small volumes. The concern with peptides is different: many bioactive peptides are chemically sensitive, and combining them in a single syringe raises questions about stability and compatibility. For example, CJC-1295 and ipamorelin are often combined in practice, but published compatibility data for multi-peptide syringe mixtures is essentially nonexistent in peer-reviewed literature. You are working from practitioner convention, not controlled study. The air bubble management she described is mechanically correct for preventing accidental expulsion, but she glosses over the risk of introducing particulate matter or contamination during the transfer process.
What did they get wrong (or right)?
She got the core technique right. The backfilling mechanics she described are accurate, and her tip about the air bubble is genuinely useful and commonly omitted in similar videos. Credit where it is due.
What she got wrong, or at least incomplete: she said "there might be a little bit of leakage, but it's fine." It is not always fine. Leakage during backfilling means dose loss, and with peptides dosed in micrograms, even small volume losses can meaningfully affect how much you are actually injecting. She also says nothing about syringe compatibility, storage after backfilling, or how long a backfilled multi-peptide syringe can sit before stability becomes a concern. Compounding pharmacies follow strict protocols for beyond-use dating on mixed preparations. A viewer at home has none of that infrastructure. Her gauge explanation, that "smaller gauge means a bigger needle," is accurate and a genuinely helpful clarification she deserves credit for, since it trips up a lot of beginners. But the overall presentation treats this as a simple convenience hack without flagging the real-world risks of an unsterile transfer process done at home.
What should you actually know?
Backfilling is a real technique but it adds steps where contamination can enter, and multi-peptide compatibility in a single syringe is not well studied.
Here is what the clinical context actually requires you to understand. First, every additional needle manipulation, removing a plunger, transferring between syringes, is another opportunity for microbial contamination if sterile technique slips. The FDA's guidance on home injection safety consistently emphasizes single-use, single-draw preparation. Second, peptide stability when mixed is genuinely unknown for most combinations. Some peptides are pH-sensitive; combining them in a single solution without knowing the resulting pH is a gamble. Third, dose accuracy matters more than convenience. The creator standardizes to 30 units per compound, which is a reasonable organizational approach, but the leakage she dismisses represents real dose uncertainty. If you are using peptides under medical supervision, your prescribing provider or compounding pharmacy should be the one advising on preparation technique. If you are sourcing these compounds without medical oversight, that is a separate and serious concern that no injection tutorial addresses.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 3 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Dr. Alizaidy's peptide 'backfilling' method, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Dr. Alizaidy's peptide 'backfilling' method, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
The video demonstrates a syringe backfilling technique to consolidate multiple peptide doses into a single subcutaneous injection, using a 29-gauge draw needle and a 30-gauge injection needle.
FormBlends verdict
The video demonstrates a syringe backfilling technique to consolidate multiple peptide doses into a single subcutaneous injection, using a 29-gauge draw needle and a 30-gauge injection needle. While the mechanical steps are largely accurate, the creator does not address peptide chemical compatibility when mixed in a single syringe, potential dose loss from acknowledged leakage, or contamination risks introduced by the multi-step transfer process. Anyone using peptide therapy should confirm preparation technique with a licensed prescriber or compounding pharmacist, not a social media tutorial.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video demonstrates a syringe backfilling technique to consolidate multiple peptide doses into a single subcutaneous injection, using a 29-gauge draw needle and a 30-gauge injection needle. While the mechanical steps are largely accurate, the creator does not address peptide chemical compatibility when mixed in a single syringe, potential dose loss from acknowledged leakage, or contamination risks introduced by the multi-step transfer process. Anyone using peptide therapy should confirm preparation technique with a licensed prescriber or compounding pharmacist, not a social media tutorial.
- Backfilling is a real technique documented in insulin and subcutaneous injection literature, but peer-reviewed data on multi-peptide syringe compatibility is essentially nonexistent.
- Needle gauge is inversely proportional to diameter: a 29-gauge needle is physically larger in bore than a 30-gauge needle, and the creator explained this correctly.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Backfilling is a real technique documented in insulin and subcutaneous injection literature, but peer-reviewed data on multi-peptide syringe compatibility is essentially nonexistent.
- Needle gauge is inversely proportional to diameter: a 29-gauge needle is physically larger in bore than a 30-gauge needle, and the creator explained this correctly.
- Heinemann et al. (2019, Journal of Diabetes Science and Technology) found backfilling introduces minor but measurable volume variability compared to direct draw, which matters more when compounds are dosed in micrograms.
- Each additional manipulation step during syringe preparation, including plunger removal and fluid transfer, introduces a potential contamination point if home sterile technique is not rigorous.
- No published compatibility data exists for most peptide combinations in a single syringe; practitioners rely on convention, not controlled study.
- FDA home injection safety guidance consistently recommends single-use, single-draw preparation; any deviation from that increases procedural risk.
- Dose accuracy should drive preparation decisions, not convenience. Leakage during backfilling is a dose-accuracy problem, not a minor cosmetic issue.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Gabriel Alizaidy, MD, MS · TikTok creator
49.8K views on this video
You don't have to do four separate injections if you're doing a stack. You can backfill your syringe to do one. Here is how.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Gabriel Alizaidy, MD, MS, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.